Five-year study will focus on brain’s immune response
brain
OMRF receives $2.2 million to study brain cells
The National Institutes of Health has awarded OMRF scientist Tommy Lewis $2.2 million to study the inner workings of brain cells.
An OMRF employee finds a new lease on life—at work
In MS, immune cells attack the protective covering of nerves in the brain, causing vision problems, tremors, paralysis, painful spasms, imbalance and cognitive changes.
OMRF scientist receives Alzheimer’s grant
Alzheimer’s affects 5.8 million Americans, and one in three senior citizens dies with the disease or other forms of dementia.
OMRF discovers compound that could fight deadly cancer
Glioblastoma is an aggressive form of brain cancer with no cure, but a new OMRF discovery offers hope.
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
